Seeking Investor for OTC Reporting Company Turnaround

This listing seeks an investor, partner, or venture capitalist for an OTC (Over-The-Counter) fully reporting company. The company previously faced reporting compliance issues, leading to its designation in the expert market. Financials and valuation have been completed, with only the 2024 quarterly reports and the 15c211 filing remaining. The funds sought will be used to finalize these processes and relist the company for trading. The opportunity also includes the potential to integrate a business with patented technology or to leverage the company's shell for other ventures. This presents a significant profit potential for investors looking to capitalize on a turnaround situation.